Abstract
Rationale and objective
This paper describes a new procedure for detecting effective antidepressant treatments. The procedure uses the swim-test susceptible (Susceptible) rat which has been selectively bred to show decreased struggling behavior in a swim test after exposure to a mild stressor. The ability of treatments to block this decrease in swim-test activity was assessed as a method for detecting effective antidepressants.
Results
In both male and female Susceptible rats, chronic (14-day) treatment with different antidepressant drugs delivered via osmotic minipump [i.e., three tricyclics (desmethylimipramine, imipramine, amitriptyline), two selective serotonin reuptake inhibitors (fluoxetine and sertraline), a monoamine oxidase inhibitor (phenelzine), and two atypical antidepressants (venlafaxine and bupropion)] all prevented the stress-induced decrease in swim-test struggling normally shown by these rats. Electroconvulsive shock had a similar effect. Unlike antidepressant drugs, 14-day treatment with various nonantidepressant drugs [i.e., a stimulant (amphetamine), an anxiolytic (chlordiazepoxide), an antihistamine (chlorpheniramine), and an anticholinergic (scopolamine)] did not have this effect. Antidepressant drug treatment for 1 day (i.e., acute treatment) was also ineffective in this test. The procedure described above requires use of the Susceptible rat—swim test resistant rats (i.e., rats selectively bred to be resistant to decreased swim-test activity after exposure to stressful conditions) showed no significant differences in swim-test behavior between stress and nonstress conditions after 14-day drug treatment, and randomly bred Sprague–Dawley rats did not show a decrease in swim-test activity following exposure to the mild stressor that is the basis for the test.
Conclusion
These results suggest that the procedure described here, which uses a rat subject that has been bred for vulnerability to stressful conditions, may be a selective screening technique for effective antidepressant treatments.
Similar content being viewed by others
References
Araki H, Kawashima K, Aihara H (1984) The difference in the site of actions of tricyclic antidepressants and methamphetamine on the duration of the immobility in the behavioral despair test. Jpn J Pharmacol 35:67–72
Benmansour S, Altamirano AV, Jones DJ, Sanchez TA, Gould GG, Pardon MC, Morilak DA, Frazer A (2004) Regulation of the norepinephrine transporter by chronic administration of antidepressants. Biol Psychiatry 55:313–316
Betin C, DeFeudis FV, Blavet N, Clostre F (1982) Further characterization of the behavioral despair test in mice: positive effects of convulsants. Physiol Behav 28:307–311
Bezchlibnyk-Butler K, Jeffries J (2001) Clinical handbook of psychotropic drugs, 11th edn. Hogrefe and Huber, Toronto
Borsini F, Meli A (1988) Is the forced swimming test a suitable model for revealing antidepressant activity? Psychopharmacology 94:147–160
Cervo L, Grignaschi G, Rossi C, Samanin R (1991) Role of central serotonergic neurons in the effect of sertraline in rats in the forced swimming test. Eur J Pharmacol 196:217–222
Cho AK, Melega WP, Kuczenski R, Segal DS (2001) Relevance of pharmacokinetic parameters in animal models of methamphetamine abuse. Synapse 39:161–166
Detke MJ, Rickels M, Lucki I (1995) Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology (Berlin) 121:66–72
Detke MJ, Johnson J, Lucki I (1997) Acute and chronic antidepressant drug treatment in the rat forced swimming test model of depression. Exp Clin Psychopharmacol 5:107–112
Garabal MF, Nunez MJ, Balboa JL, Suarez JA, Belmonte A (1991) Effects of alpraxolam on the development of MTV-induced mammary tumors in female mice under stress. Cancer Lett 62:185–189
Gram LF, Sondergaard I, Christiansen J, Petersen GO, Bech P, Reisby N, Ibsen I, Ortmann J, Nagy A, Dencker SJ, Jacobsen O, Krautwald O (1977) Steady-state kinetics of imipramine in patients. Psychopharmacology 54:255–261
Grant MM, Weiss JM (2001) Effects of chronic antidepressant drug administration and electroconvulsive shock on locus coeruleus electrophysiologic activity. Biol Psychiatry 49:117–129
Haddjeri N, Blier P, de Montigny C (1997) Effects of long-term treatment with the a2-adrenoceptor antagonist mirtazapine on 5-HT neurotransmission. Naunyn-Schmiedeberg's Arch Pharmacol 355:20–29
Heller A, Zahourek R, Whittington HG (1971) Effectiveness of antidepressant drugs: a triple-blind study comparing imipramine, desipramine, and placebo. Am J Psychiatry 127:1092–1095
Katz MM, Koslow SH, Frazer A (1996/1997) Onset of antidepressant activity: Reexamining the structure of depression and multiple actions of drugs. Depress Anxiety 4:257–267
Kitada Y, Miyauchi T, Satoh A, Satoh S (1981) Effects of antidepressants in the rat forced swimming test. Eur J Pharmacol 72:145–152
Miyauchi T, Kitada Y, Satoh S (1981) Effects of acutely and chronically administered antidepressants on the brain regional 3-methoxy-4-hydroxyphenylethyleneglycol sulphate in the forced swimming rat. Life Sci 29:1921–1928
Nies A, Robinson DS, Friedman MJ, Green R, Cooper TB, Ravaris CL, Ives JO (1977) Relationship between age and tricyclic antidepressant plasma levels. Am J Psychiatry 134:790–793
Overstreet DH (1986) Selective breeding for increased cholinergic function: development of a new model of depression. Biol Psychiatry 21:49–58
Overstreet DH (1993) The Flinders Sensitive line rats: a genetic animal model of depression. Neurosci Biobehav Rev 17:51–68
Overstreet DH, Pucilowski O, Rezvani AH, Janowsky DS (1995) Administration of antidepressants, diazepam and psychomotor stimulants further confirms the utility of Flinders Sensitive Line rats as an animal model of depression. Psychopharmacology 121:27–37
Porsolt RD, Le Pichon M, Jalfre M (1977) Depression: a new animal model sensitive to antidepressant procedures. Nature 226:730–732
Porsolt RD, Anton G, Blavet N, Jalfre M (1978) Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur J Pharmacol 47:379–391
Porsolt RD, Bertin A, Blavet N, Deniel M, Jalfre M (1979) Immobility induced by forced swimming in rats: effects of agents which modify central catecholamine and serotonin activity. Eur J Pharmacol 57:201–210
Porsolt RD, Lenegre A, McArthur RA (1991) Pharmacological models of depression. In: Olivier B, Mos J, Slangen JL (eds) Animal models of psychopharmacology. Birkhauser Verlag, Basel, pp 137–159
Preskorn SH (1989) Tricyclic antidepressants: the whys and hows of therapeutic drug monitoring. J Clin Psychiatry 50(Suppl):34–42
Rivière GJ, Gentry WB, Owens SM (2000) Disposition of methamphetamine and its metabolite amphetamine in brain and other tissues in rats after intravenous administration. J Pharmacol Exp Ther 292:1042–1047
Satoh H, Mori J, Shimomura K, Ono T, Kikuchi H (1984) Effect of zimeldine, a new antidepressant, on the forced swimming test in rats. Jpn J Pharmacol 35:471–473
Scott PA, Cierpial MA, Kilts CD, Weiss JM (1996) Susceptibility and resistance of rats to stress-induced decreases in swim-test activity: a selective breeding study. Brain Res 725:217–230
Sherman AD, Sacquitne JL, Petty F (1982) Specificity of the learned helplessness model of depression. Pharmacol Biochem Behav 16:449–454
Stewart JA, Mitchell PH (1968) A comparative trial of desipramine and nortriptyline in depression. Br J Psychiatry 114:469–471
Szabo ST, Blier P (2001) Effect of the selective noradrenegeric reuptake inhibitor reboxetine on the firing activity of noradrenaline and serotin neurons. Eur J Neurosci 13:2077–2087
Van Brunt N (1983) The clinical utility of tricyclic antidepressant blood levels: a review of the literature. Ther Drug Monit 5:1–10
Wallach MB, Hedley LR (1979) The effects of antihistamines in a modified behavioral despair test. Commun Psychopharmacol 3:35–39
Weiss JM, Kilts CD (1998) Animal models of depression and schizophrenia. In: Nemeroff CB, Schatzberg AF (eds) The American Psychiatric Press textbook of psychopharmacology. American Psychiatric Press, Inc., Washington, DC, pp 89–131
Weiss JM, Cierpial MA, West CHK (1998) Selective breeding of rats for high and low motor activity in a swim test: toward a new animal model of depression. Pharmacol Biochem Behav 61:49–66
Weiss JM, Goodman PA, Losito BG, Corrigan S, Charry JM, Bailey WH (1981) Behavioral depression produced by an uncontrollable stressor: relationship to norepinephrine, dopamine, and serotonin levels in various regions of the rat brain. Brain Res Rev 3:167–205
West CHK, Weiss JM (1998) Effects of antidepressant drugs on rats bred for low activity in the swim test. Pharmacol Biochem Behav 61:67–79
Acknowledgements
This research was supported by the Theodore and Vada Stanley Foundation of the National Alliance for the Mentally Ill (NAMI). We acknowledge with appreciation the following pharmaceutical companies for generously providing the indicated drugs: Eli Lilly, Indianapolis, IN (fluoxetine), Wyeth-Ayerst, Princeton, NJ (venlafaxine), Burroughs Wellcome, Research Triangle Park, NC (bupropion), and Pfizer, Groton, CN, (sertraline). The authors gratefully acknowledge the excellent technical assistance of Sandra Parks and Lorna Clarke in the preparation of this manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
West, C.H.K., Weiss, J.M. A selective test for antidepressant treatments using rats bred for stress-induced reduction of motor activity in the swim test. Psychopharmacology 182, 9–23 (2005). https://doi.org/10.1007/s00213-005-0048-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00213-005-0048-x